A/RES/77/238 GA
Addressing and countering the world drug problem through a comprehensive, integrated and balanced approach : resolution / adopted by the General Assembly
77
Session
124
Yes
9
No
45
Abstentions
| Draft symbol | A/C.3/77/L.13/Rev.1 |
|---|---|
| Adopted symbol | A/RES/77/238 |
| Category | SOCIAL CONDITIONS AND EQUITY |
| P5 Positions |
|
| UN Document | A/RES/77/238 ↗ |
Vote Recorded Vote — A/77/PV.54
-
Algeria
-
Azerbaijan
-
Bahrain
-
Bangladesh
-
Central African Republic
-
China
-
Cuba
-
Democratic People's Republic of Korea
-
Djibouti
-
Egypt
-
Eritrea
-
Ethiopia
-
Guinea-Bissau
-
India
-
Indonesia
-
Iraq
-
Kazakhstan
-
Kenya
-
Kuwait
-
Kyrgyzstan
-
Lao People's Democratic Republic
-
Libya
-
Madagascar
-
Malaysia
-
Mali
-
Mauritania
-
Mauritius
-
Namibia
-
Oman
-
Qatar
-
Saint Kitts and Nevis
-
Saudi Arabia
-
Senegal
-
Singapore
-
Sri Lanka
-
Sudan
-
Tajikistan
-
Togo
-
Tunisia
-
Uganda
-
United Arab Emirates
-
United Republic of Tanzania
-
Uzbekistan
-
Viet Nam
-
Yemen
-
Afghanistan
-
Albania
-
Andorra
-
Angola
-
Antigua and Barbuda
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Bahamas
-
Barbados
-
Belgium
-
Belize
-
Bhutan
-
Plurinational State of Bolivia
-
Bosnia and Herzegovina
-
Botswana
-
Brazil
-
Brunei Darussalam
-
Bulgaria
-
Burkina Faso
-
Cabo Verde
-
Cambodia
-
Canada
-
Chad
-
Chile
-
Colombia
-
Congo
-
Costa Rica
-
Côte d'Ivoire
-
Croatia
-
Cyprus
-
Czechia
-
Democratic Republic of the Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
El Salvador
-
Equatorial Guinea
-
Estonia
-
Eswatini
-
Fiji
-
Finland
-
France
-
Gabon
-
Gambia
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Grenada
-
Guatemala
-
Guinea
-
Guyana
-
Haiti
-
Honduras
-
Hungary
-
Iceland
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kiribati
-
Latvia
-
Lebanon
-
Lesotho
-
Liberia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malawi
-
Maldives
-
Malta
-
Marshall Islands
-
Mexico
-
Micronesia (Federated States of)
-
Monaco
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Nepal
-
Netherlands
-
New Zealand
-
North Macedonia
-
Norway
-
Palau
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Republic of Korea
-
Moldova
-
Romania
-
Saint Lucia
-
Saint Vincent and the Grenadines
-
Samoa
-
San Marino
-
Serbia
-
Sierra Leone
-
Slovakia
-
Slovenia
-
Solomon Islands
-
South Africa
-
Spain
-
Suriname
-
Sweden
-
Switzerland
-
Thailand
-
Timor-Leste
-
Trinidad and Tobago
-
Tuvalu
-
Ukraine
-
United Kingdom of Great Britain and Northern Ireland
-
United States of America
-
Uruguay
-
Zambia
-
Zimbabwe
Full text of resolution
United Nations
A/RES/77/238
General Assembly
Distr.: General
10 January 2023
22-29004 (E) 130123
*2229004*
Seventy-seventh session
Agenda item 111
International drug control
Resolution adopted by the General Assembly
on 15 December 2022
[on the report of the Third Committee (A/77/466, para. 12)]
77/238. Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
The General Assembly,
Underscoring that the Single Convention on Narcotic Drugs of 1961 as amended
by the 1972 Protocol,1 the Convention on Psychotropic Substances of 1971,2 the
United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic
Substances of 19883 and other relevant international instruments constitute the
cornerstone of the international drug control system,
Reaffirming the outcome document of the thirtieth special session of the
General Assembly, entitled “Our joint commitment to effectively addressing and
countering the world drug problem”,4 in its entirety, and reiterating that the operational
recommendations contained therein are integrated, indivisible, multidisciplinary and
mutually reinforcing and are aimed at a comprehensive, integrated and balanced
approach to addressing and countering the world drug problem,
Welcoming the 2019 Ministerial Declaration on Strengthening Our Actions at
the National, Regional and International Levels to Accelerate the Implementation of
Our Joint Commitments to Address and Counter the World Drug Problem5 adopted at
the ministerial segment of the sixty-second session of the Commission on Narcotic
Drugs, which was held to take stock of the implementation of the commitments made
over the past decade to jointly address and counter the world drug problem,
__________________
1 United Nations, Treaty Series, vol. 976, No. 14152.
2 Ibid., vol. 1019, No. 14956.
3 Ibid., vol. 1582, No. 27627.
4 Resolution S-30/1, annex.
5 See Official Records of the Economic and Social Council, 2019, Supplement No. 8 (E/2019/28),
chap. I, sect. B.
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
2/15
Reaffirming the 2009 Political Declaration and Plan of Action on International
Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug
Problem6 and the Joint Ministerial Statement of the 2014 high-level review by the
Commission on Narcotic Drugs of the implementation by Member States of the
Political Declaration and Plan of Action,7 and recalling the resolutions adopted at the
twentieth special session of the General Assembly,8
Reaffirming also the Universal Declaration of Human Rights,9 and recalling the
International Covenant on Economic, Social and Cultural Rights,10 the International
Covenant on Civil and Political Rights,11 the Vienna Declaration and Programme of
Action12 and other relevant international human rights instruments,
Recalling all relevant United Nations resolutions, including all resolutions and
decisions adopted by the Commission on Narcotic Drugs,
Reaffirming its resolution 76/188 of 16 December 2021 and all its preceding
resolutions on international cooperation to address and counter the world drug
problem,
Reaffirming also its unwavering commitment to ensuring that all aspects of
demand reduction and related measures, supply reduction and related measures, and
international cooperation are addressed in full conformity with the purposes and
principles of the Charter of the United Nations, international law and the Universal
Declaration of Human Rights, with full respect for the sovereignty and territorial
integrity of States, the principle of non-intervention in the internal affairs of States,
all human rights, fundamental freedoms, the inherent dignity of all individuals and
the principles of equal rights and mutual respect among States,
Reaffirming the 2030 Agenda for Sustainable Development,13 and noting that
efforts to achieve the Sustainable Development Goals and to effectively address the
world drug problem are complementary and mutually reinforcing,
Reaffirming also the principal role of the Commission on Narcotic Drugs as the
policymaking body of the United Nations system with prime responsibility for drug
control matters, as well as the treaty-mandated functions of the Commission to
consider and make recommendations relating to all matters pertaining to the aims and
provisions of the United Nations drug conventions, reaffirming also the support and
appreciation of the General Assembly for the efforts of the United Nations, in
particular those of the United Nations Office on Drugs and Crime as the leading entity
in the United Nations system for addressing and countering the world drug problem,
reaffirming further the treaty-mandated roles of the International Narcotics Control
Board and the World Health Organization, and recognizing the role and contributions
of the United Nations Development Programme, the Office of the United Nations
High Commissioner for Human Rights, the Joint United Nations Programme on
HIV/AIDS and the United Nations Entity for Gender Equality and the Empowerment
of Women (UN-Women), among other agencies, within their respective mandates,
Recalling Human Rights Council resolution 37/42 of 23 March 2018, entitled
“Contribution to the implementation of the joint commitment to effectively
__________________
6 Ibid., 2009, Supplement No. 8 (E/2009/28), chap. I, sect. C.
7 Ibid., 2014, Supplement No. 8 (E/2014/28), chap. I, sect. C.
8 Resolutions S-20/1, S-20/2, S-20/3 and S-20/4 A–E.
9 Resolution 217 A (III).
10 See resolution 2200 A (XXI), annex.
11 Ibid.
12 A/CONF.157/24 (Part I), chap. III.
13 Resolution 70/1.
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
3/15
22-29004
addressing and countering the world drug problem with regard to human rights”,14
and taking note of the efforts to address arbitrary detention related to drug policies,
Recalling also Commission on Narcotic Drugs resolution 65/2 of 18 March 2022
on strengthening international cooperation to address the links between illicit drug
trafficking and illicit firearms trafficking,15
Recalling further Commission on Narcotic Drugs resolution 65/4 of 18 March
2022 on promoting comprehensive and scientific evidence-based early prevention,16
Taking note of the World Drug Report 2022, which reflects the current trends on
global drug markets,
Recognizing that the three international drug control conventions concern the
health and welfare of humankind and that human rights are an indispensable part of
the international legal framework for the design and implementation of drug policies,
and bearing in mind efforts to address the human rights consequences of the world
drug problem,
Noting with appreciation the contributions of United Nations entities,
international financial institutions and relevant regional and international
organizations, within their respective mandates, to the work of the Commission on
Narcotic Drugs and the efforts of Member States to address and counter the world
drug problem, upon their request, to strengthen international and inter-agency
cooperation, and encouraging them to make available relevant information to the
Commission on Narcotic Drugs in order to facilitate its work and to enhance
coherence within the United Nations system at all levels with regard to the world drug
problem,
Recalling relevant United Nations standards and norms in crime prevention and
criminal justice, including the United Nations Rules for the Treatment of Women
Prisoners and Non-custodial Measures for Women Offenders (the Bangkok Rules),17
the United Nations Standard Minimum Rules for Non-custodial Measures (the Tokyo
Rules)18 and the United Nations Standard Minimum Rules for the Treatment of
Prisoners (the Nelson Mandela Rules),19
Recalling also the need to develop, adopt and implement, with due regard for
national, constitutional, legal and administrative systems, alternative or additional
measures with regard to conviction or punishment in cases of an appropriate nature,
in accordance with the three international drug control conventions and taking into
account, as appropriate, relevant United Nations standards and rules, such as the
Tokyo Rules,
Condemning any discriminatory or violent practice perpetrated by law
enforcement officials against persons who are vulnerable or marginalized, including
systemic racism in the law enforcement and criminal justice systems, underscoring
the importance of ensuring that such acts are not treated with impunity, and, in this
regard, taking note of the request of the Human Rights Council, through its resolution
42/22 of 26 September 2019,20 that the Working Group on Arbitrary Detention, within
__________________
14 See Official Records of the General Assembly, Seventy-third Session, Supplement No. 53
(A/73/53), chap. IV, sect. A.
15 See Official Records of the Economic and Social Council, 2022, Supplement No. 8 (E/2022/28),
chap. I, sect. B.
16 Ibid.
17 Resolution 65/229, annex.
18 Resolution 45/110, annex.
19 Resolution 70/175, annex.
20 See Official Records of the General Assembly, Seventy-fourth Session, Supplement No. 53A
(A/74/53/Add.1), chap. III.
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
4/15
its mandate, prepare a study on arbitrary detention related to drug policies, which was
published on 18 May 2021,
Recognizing the importance of appropriately mainstreaming gender and age
perspectives into drug-related policies and programmes, as well as the full, equal,
meaningful and effective participation of women and young persons in their design
and implementation,
Recognizing also the need to enhance efforts to strengthen the prevention of
drug abuse among children and youth, also in educational settings, including by
promoting the exchange of experiences and good practices, as well as technical
assistance, and recalling Commission on Narcotic Drugs resolution 61/2 of 16 March
2018 on strengthening efforts to prevent drug abuse in educational settings,21
Expressing deep concern at the high price paid by society and by individuals
and their families as a result of the world drug problem, and paying special tribute to
those who have sacrificed their lives, including law enforcement and judicial
personnel, and to the health-care and civil society personnel and volunteers whose
work is dedicated to countering and addressing this phenomenon,
Reaffirming that Indigenous Peoples have the right to their traditional medicines
and to maintain their health practices, including the conservation of their vital
medicinal plants, animals and minerals, and that they also have the right to access,
without any discrimination, to all social and health services and to participate in
decision-making processes, in accordance with United Nations Declaration on the
Rights of Indigenous Peoples,22
Welcoming continued efforts to enhance coherence within the United Nations
system at all levels, and reaffirming the need to continue and strengthen cooperation
between the United Nations Office on Drugs and Crime and other United Nations
entities, including the World Health Organization and the International Narcotics
Control Board, within their respective mandates, in their efforts to support Member
States in the implementation of international drug control treaties in accordance with
applicable human rights obligations and to promote protection of and respect for
human rights, fundamental freedoms and the dignity of all individuals in the context
of drug programmes, strategies and policies,
Expressing its appreciation for the results already achieved by the initiatives at
the bilateral, regional and international levels, recognizing that further positive results
can be achieved with sustained and collective efforts through international
cooperation in reducing the demand and supply of illicit drugs, recognizing also that
the world drug problem continues to present challenges to the health, including
mental health, safety and well-being of all humanity, and resolving to reinforce
national and international efforts and further increase international cooperation to
face those challenges,
Reaffirming the crucial role of Member States in developing an effective and
comprehensive approach to addressing and countering the world drug problem,
Recognizing that there are persistent, new and evolving challenges that should
be addressed in conformity with the three international drug control conventions,
which allow for sufficient flexibility for States parties to design and implement
national drug policies according to their priorities and needs, consistent with the
principle of common and shared responsibility and applicable international law,
__________________
21 See Official Records of the Economic and Social Council, 2018, Supplement No. 8 (E/2018/28),
chap. I, sect. B.
22 Resolution 61/295, annex.
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
5/15
22-29004
Recognizing also that the world drug problem remains a common and shared
responsibility that should be addressed in a multilateral setting through effective and
increased international cooperation and demands an integrated, multidisciplinary,
mutually reinforcing, balanced, scientific evidence-based and comprehensive approach,
Reaffirming the need for close cooperation and coordination among domestic
authorities at all levels to address the key causes and consequences of the world drug
problem, including those in the health, education, social, human rights, economic,
justice, public security and law enforcement fields, in line with the principle of
common and shared responsibility, and recognizing the value of comprehensive and
balanced policy interventions, including those in the field of promotion of sustainable
and viable livelihoods,
Recognizing, as part of a comprehensive, integrated and balanced approach to
addressing and countering the world drug problem, that appropriate emphasis should
be placed on individuals, families, communities and society as a whole, with a view
to promoting and protecting the health, safety and well-being of all humanity,
Reaffirming equally that reducing drug abuse requires efforts to reduce demand,
which must be demonstrated by sustained widespread demand reduction initiatives
that are age- and gender-responsive and integrate a comprehensive public health
approach spanning the spectrum of prevention, education, early detection and
intervention, treatment, care and related support services, recovery support and the
rehabilitation and social reintegration of drug users, in full compliance with the three
international drug control conventions,
Deeply concerned that drug traffickers are heavily arming themselves with
trafficked firearms, exposing people and law enforcement personnel to significant
levels of violence and harm,
Welcoming the progress made in strengthening and expanding existing
cooperation on the public health-related aspects of the world drug problem, including
progress related to minimizing its adverse public health and social consequences, and
reaffirming the need to take into account both the public health and the criminal
justice dimensions of the world drug problem, in accordance with the outcome
document of the thirtieth special session of the General Assembly, including by
intensifying efforts to support Member States, upon request, in addressing and
countering the world drug problem in accordance with a comprehensive, integrated
and balanced approach,
Mindful of the importance of encouraging the voluntary engagement and
participation of individuals with drug use disorders in treatment programmes, with
informed consent, where consistent with national legislation, and developing and
implementing scientific evidence-based outreach programmes and campaigns,
involving affected populations, including those in long-term recovery, where
appropriate, to promote healthy lifestyles and reduce the adverse health and social
consequences of the world drug problem, prevent social marginalization and promote
non-stigmatizing attitudes, as well as of implementing effective outreach to engage
and maintain the engagement of people who are in treatment, care or sustained
recovery programmes and taking measures to facilitate access to such programmes
and related support services, including treatment for comorbidities, and to expand
capacity,
Recognizing that rapid technological change has helped address some of the
challenges posed by the coronavirus disease (COVID-19) pandemic, including
through remote consultations for drug treatment services, telemedicine and greater
flexibility in the provision and delivery of medication, while also recognizing the
need to address the challenges posed by changes in trafficking routes and methods,
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
6/15
including increased maritime trafficking, and online sales of drugs through both the
darknet and the surface web,
Recognizing also the consequences of the COVID-19 pandemic on all aspects
of the world drug problem, including the social impacts, such as increased
unemployment, weakened social support systems, lack of access to treatment and
recovery support services, and deepened inequalities, resulting in the development of
new patterns of illicit drug use and the illicit cultivation, production and manufacture
of and trafficking in drugs that may have also resulted in new methods of
manufacture, distribution and marketing of and trafficking in some types of drugs,
including increased online sales of drugs through both the darknet and the surface
web,
Noting with grave concern the increasing sophistication of the transnational
criminal groups engaged in the illicit manufacture and distribution of amphetamine-
type stimulants worldwide, as well as the proliferation and diversion of chemical
precursors used in the illicit manufacture of narcotic drugs and psychotropic
substances, and deeply concerned that new psychoactive substances continue to be a
challenge, including the increased abuse of certain drugs and the proliferation of new
substances worldwide, which are a possible threat to public health and are not
controlled under the three international drug control conventions,
Reaffirming that alternative development is an important, lawful, viable and
sustainable alternative to the illicit cultivation of drug crops and an effective measure
to counter the world drug problem and other drug-related crime challenges, and
reaffirming also its commitment to addressing drug-related socioeconomic issues
related to the illicit cultivation, manufacture and production of and trafficking in
drugs through the implementation of long-term, comprehensive and sustainable
development-oriented and balanced drug control policies and programmes, including
alternative development and, as appropriate, preventive alternative development
programmes, which are part of sustainable crop control strategies,
Reaffirming also the need to mobilize adequate resources to address and counter
the world drug problem, and calling for the enhancement of assistance to developing
countries, upon request, in effectively implementing the Political Declaration and
Plan of Action on International Cooperation towards an Integrated and Balanced
Strategy to Counter the World Drug Problem and the operational recommendations of
the outcome document of the thirtieth special session of the General Assembly,
Expressing concern that aspects of the world drug problem associated with illicit
drug production and illicit cultivation of drug crops can cause serious harm to the
environment, including food security, deforestation, soil erosion and degradation, the
loss of endemic species, contamination of the soil, groundwater and waterways, and
the release of greenhouse gases,
Recalling the commitment of Member States in the 2019 Ministerial Declaration
to review in the Commission on Narcotic Drugs in 2029 the progress in implementing
all international drug policy commitments, with a midterm review in the Commission
in 2024,
1.
Reiterates its commitment to promoting the health, welfare and well-being
of all individuals, families, communities and society as a whole and to facilitating
healthy lifestyles through effective, comprehensive, scientific evidence-based
demand reduction initiatives at all levels, covering, in accordance with national
legislation and the three international drug control conventions, prevention, early
intervention, treatment, care, recovery, rehabilitation and social reintegration
measures, as well as initiatives and measures aimed at minimizing the adverse public
health and social consequences of drug abuse;
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
7/15
22-29004
2.
Reaffirms its commitment to respecting, protecting and promoting all
human rights, fundamental freedoms and the inherent dignity of all individuals and
the rule of law in the development and implementation of drug policies;
3.
Reaffirms the determination of Member States to tackle the world drug
problem, while also recognizing the need to address the key causes and consequences
of the world drug problem, including those in the health, social, human rights,
economic, justice, public security and law enforcement fields, in line with the principle
of common and shared responsibility, further reaffirms the determination of Member
States to address public health, safety and social problems resulting from drug abuse,
and recognizes the value of comprehensive and balanced policy interventions,
including those in the field of the promotion of sustainable and viable livelihoods;
4.
Calls upon Member States to promote bilateral, regional and international
cooperation with and technical assistance to the States most affected by illicit crop
cultivation and the illicit production, manufacture, transit, trafficking, distribution
and abuse of narcotic drugs and psychotropic substances, including synthetic drugs,
in developing and implementing comprehensive and integrated policies, including
through intelligence-sharing and cross-border cooperation, and by reinforcing
national programmes aimed at education, prevention, early intervention, treatment,
care, rehabilitation and social reintegration;
5.
Welcomes the ongoing efforts to strengthen cooperation in addressing and
countering the world drug problem and to seek effectiveness and comprehensiveness
in the strategies and policies undertaken by regional and subregional organizations
and transregional initiatives;
6.
Calls upon Member States to engage in effective cooperation and practical
action, including North-South, South-South and triangular cooperation, in cooperation
with the international development community and other key stakeholders, aimed at
addressing and countering the world drug problem on the basis of the principle of
common and shared responsibility;
7.
Also calls upon Member States to strengthen regional, subregional and
international cooperation in criminal matters, as appropriate, including judicial
cooperation in the areas of, inter alia, extradition, mutual legal assistance and transfer
of proceedings, in accordance with the three international drug control conventions
and other international legal instruments and national legislation, and to strive to
provide appropriate resources to national competent authorities, including through
the provision of targeted technical assistance to requesting countries;
8.
Encourages Member States to promote the prevention and treatment of
drug use disorders, using scientific evidence-based practices, and takes note of the
second updated edition of the International Standards on Drug Use Prevention and
the International Standards for the Treatment of Drug Use Disorders, developed by
the United Nations Office on Drugs and Crime in collaboration with the World Health
Organization, that reflect respect for human rights and dignity, including the right to
enjoy the highest attainable standard of physical and mental health and well-being,
including mental health and psychosocial support services, promoting non-stigmatizing
attitudes in the development and implementation of scientific evidence-based
policies;
9.
Recognizes drug dependence as a complex, multifactorial health disorder
characterized by a chronic and relapsing nature, with social causes and consequences,
that can be prevented and treated through, inter alia, effective scientific evidence-
based drug treatment, care and rehabilitation programmes, including community-
based programmes, and also recognizes the need to strengthen capacity for aftercare
for and the rehabilitation, recovery and social reintegration of individuals with
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
8/15
substance use disorders, including mental health and psychosocial support services
and, as appropriate, through assistance for effective reintegration into the labour
market and other support services;
10. Encourages Member States to develop quality assurance mechanisms for
drug prevention, treatment, including for comorbidities, sustained recovery and
related support services that reduce the adverse health and social consequences of
drug abuse with a view to ensuring continuous improvement, through, inter alia,
effective supervision of drug treatment and rehabilitation facilities by competent
domestic authorities, including to prevent any possible acts of cruel, inhuman or
degrading treatment or punishment, in accordance with national legislation and
applicable international law;
11. Also encourages Member States to promote the inclusion in national drug
policies, in accordance with national legislation and as appropriate, of elements for
the prevention and treatment of drug overdose, in particular opioid overdose,
including the use of opioid receptor antagonists, such as naloxone, to reduce drug-
related mortality;
12. Urges Member States to increase the availability, coverage and quality of
scientific evidence-based prevention measures and tools, especially life skills
programmes with demonstrated effectiveness, that target relevant age and risk groups
in multiple settings, including in educational institutions, in both the public and
private sectors, reaching youth in school as well as out of school, among others,
including by providing children and youth with information on drug abuse and its
harmful effects and consequences as well as through drug use prevention programmes
and public awareness-raising campaigns, including by using the Internet, social media
and other online platforms, to develop and implement prevention curricula and early
intervention programmes for use in the education system at all levels, as well as in
vocational training, including in the workplace, and to enhance the capacity of
teachers and other relevant professionals, as well as that of parents and guardians, to
provide or recommend counselling, prevention and health-care services, and
opportunities to choose healthy lifestyles, and to promote safe and drug-free
environments;
13. Invites Member States to consider enhancing cooperation among public
health, education and law enforcement authorities when developing and implementing
evidence-based drug use prevention initiatives;
14. Acknowledges the important advances made in prevention science,
establishing prevention as one of the main components of comprehensive, scientific
evidence-based demand-reduction initiatives to address the non-medical use of
controlled drugs, and also acknowledges that effective early prevention strategies and
measures focused on addressing, inter alia, adverse childhood experiences as well as
individual and environmental, including social, risk and protective, factors, contribute
significantly to the positive engagement of children, youth and adults with their
families and in educational settings, workplaces and communities;
15. Reiterates the strong commitment of Member States to improve access to
controlled substances for medical and scientific purposes by appropriately addressing
existing barriers in this regard, while concurrently preventing the diversion and abuse
of and trafficking in such substances, and to strengthen, as appropriate, the proper
functioning of national drug control systems and domestic assessment mechanisms
and programmes, with a view to promoting the health and welfare of humankind, in
cooperation with the International Narcotics Control Board, the United Nations Office
on Drugs and Crime, the World Health Organization and other relevant United
Nations system agencies, to identify, analyse and remove impediments to the
availability and accessibility of controlled substances for medical and scientific
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
9/15
22-29004
purposes, within appropriate control mechanisms, as required by the three
international drug control conventions and, for that purpose, to consider the provision
of technical and financial assistance, upon request, to developing countries;
16. Urges Member States to reduce the adverse health and social consequences
of the world drug problem through a comprehensive approach, including by utilizing
existing United Nations Office on Drugs and Crime technical assistance tools, and
ensuring that evidence-based treatment is available;
17. Urges Member States and other donors to continue to provide bilateral and
other funding for the global drug problem response, including in particular the
HIV/AIDS response, including to the Joint United Nations Programme on HIV/AIDS,
and to strive to ensure that such funding contributes to addressing the growing
HIV/AIDS epidemic among people who inject drugs, and HIV/AIDS in prison
settings, in the spirit of the pledge made in the 2030 Agenda for Sustainable
Development to leave no one behind;
18. Encourages Member States to consider alternative, non-custodial
measures for persons accused of minor, non-violent drug-related offences, to
promote, consistent with the three international drug control conventions and
domestic law, and in accordance with national, constitutional, legal and
administrative systems, alternative or additional measures with regard to conviction
or punishment in cases of an appropriate nature, and to ensure that law enforcement
drug control efforts are consistent with States’ human rights obligations;
19. Calls upon Member States to promote and implement effective criminal
justice responses to drug-related crimes to bring perpetrators to justice that ensure
legal guarantees and due process safeguards pertaining to criminal justice
proceedings, including practical measures to uphold the prohibition of arbitrary arrest
and detention and of torture and other cruel, inhuman or degrading treatment or
punishment and to eliminate impunity, in accordance with relevant and applicable
international law and taking into account United Nations standards and norms on
crime prevention and criminal justice, and ensure timely access to legal aid and the
right to a fair trial;
20. Encourages Member States to promote proportionate national sentencing
policies, practices and guidelines for drug-related offences, whereby the severity of
penalties is proportionate to the gravity of offences and both mitigating and
aggravating factors are taken into account, including the circumstances enumerated
in article 3 of the United Nations Convention against Illicit Traffic in Narcotic Drugs
and Psychotropic Substances of 1988 and other relevant and applicable international
law, and in accordance with national legislation;
21. Urges Member States to take further steps to prevent the use and diversion
of synthetic drugs for non-medical purposes, including through measures and
initiatives addressing the training of relevant health-care professionals and, where
appropriate, education and raising public awareness and engaging with the private
sector on, inter alia, issues related to marketing;
22. Reiterates its commitment to protect the safety and assure the security of
individuals, societies and communities by intensifying efforts to prevent and counter
the illicit cultivation, production and manufacture of and trafficking in narcotic drugs
and psychotropic substances, as well as drug-related crime and violence, through,
inter alia, more effective drug-related crime prevention and law enforcement
measures, as well as by addressing links with other forms of organized crime,
including firearms trafficking, money-laundering, corruption and other criminal
activities, mindful of their social and economic causes and consequences;
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
10/15
23. Calls upon Member States to enhance national, regional, subregional,
interregional and international capacity, and utilize existing and relevant regional and,
as appropriate, subregional and international networks for the exchange of operational
information to respond to the serious challenges posed by the increasing links
between drug trafficking, corruption and other forms of organized crime, including
trafficking in persons, trafficking in firearms, cybercrime and money-laundering, and,
in some cases, terrorism, including money-laundering in connection with the
financing of terrorism, by using an integrated and multidisciplinary approach, such
as through promoting and supporting reliable data collection, research and, as
appropriate, intelligence- and analysis-sharing to ensure effective policymaking and
interventions, by using, inter alia, existing United Nations Office on Drugs and Crime
technical assistance tools;
24. Also calls upon Member States to adopt and strengthen coordinated border
management strategies, if needed, to prevent, monitor and counter the illicit
production, manufacture and trafficking of narcotic drugs and psychotropic
substances, including when associated with other forms of transnational organized
crime, such as trafficking in firearms, illicit financial flows, smuggling of goods and
of bulk cash, and money-laundering, and also calls upon Member States to provide
technical assistance, upon request, including where appropriate the provision of
equipment and technology, along with necessary training and maintenance support,
to increase the capacity of border and law enforcement agencies, in particular for
developing countries;
25. Recognizes that transit States continue to face multifaceted challenges, and
reaffirms the continuing need for cooperation and support, including the provision of
technical assistance, to, inter alia, enhance their capacities to effectively address and
counter the world drug problem, in conformity with the 1988 Convention;
26. Reiterates its commitment to strengthen specialized, targeted, effective and
sustainable technical assistance, including, where appropriate, adequate financial
assistance, training, capacity-building, equipment and technological know-how, to
requesting countries, including transit countries, through and in cooperation with the
United Nations Office on Drugs and Crime, as well as the World Health Organization
and other relevant United Nations entities and international and regional
organizations, within their respective mandates, so as to help Member States to
effectively address the health, socioeconomic, human rights, justice and law
enforcement aspects of the world drug problem;
27. Calls upon Member States to strengthen national and international action
to address the emerging challenge of new psychoactive substances, including their
adverse health consequences, and the evolving threat of amphetamine-type
stimulants, including methamphetamine, underscores the importance of enhancing
information-sharing and early warning networks, developing appropriate national
legislative, prevention and treatment models and supporting scientific evidence-based
review and scheduling of the most prevalent, persistent and harmful substances, and
notes the importance of preventing the diversion and misuse of pharmaceuticals
containing narcotic drugs and psychotropic substances and precursors, while ensuring
their availability for legitimate purposes;
28. Encourages Member States to ensure that measures to prevent the illicit
cultivation of and to eradicate plants containing narcotic and psychotropic substances
respect fundamental human rights, take due account of traditional licit uses, where
there is historical evidence of such use, and of the protection of the environment, in
accordance with the three international drug control conventions, and also take into
account, as appropriate and in accordance with domestic law, the United Nations
Declaration on the Rights of Indigenous Peoples;
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
11/15
22-29004
29. Also encourages Member States to improve the assessment of the impact
of demand and supply reduction strategies, including the impact of alternative
development programmes and preventive alternative development programmes, as
appropriate, with a view to increasing the effectiveness of such programmes,
including through the use of relevant human development indicators, criteria related
to environmental sustainability and other measurements in line with the Sustainable
Development Goals;
30. Further encourages Member States to examine and address, within the
efforts of alternative development, the harmful impact of the illicit cultivation of
crops used for the production of narcotic drugs on the environment, which leads to
illegal deforestation, the pollution of soil and water, and negative consequences on
food safety, and to seize the opportunities offered by alternative development with
regard to the conservation and sustainable use of the environment and the protection
of biodiversity;
31. Recognizes the need for strengthening sustainable crop control strategies
that may include, inter alia, alternative development, eradication and law enforcement
measures, and in this regard encourages Member States to consider development-
oriented interventions to address the illicit cultivation of drug crops and other illicit
drug-related activities, while ensuring that both men and women benefit equally from
them, including through job opportunities, improved infrastructure and basic public
services and, as appropriate, access and legal titles to land for farmers and local
communities;
32. Reiterates its commitment to strengthen subregional, regional and
international cooperation, in accordance with the principle of common and shared
responsibility, to support comprehensive and sustainable alternative development
programmes, including, as appropriate, preventive alternative development, in close
collaboration with all relevant stakeholders at the local, national and international
levels, and to develop and share best practices towards implementing the United
Nations Guiding Principles on Alternative Development,23 taking into account all the
lessons learned and good practices, in particular by countries with extensive expertise
in alternative development, and in this regard recalls its resolution 72/197 of
19 December 2017, as well as Commission on Narcotic Drugs resolution 65/1 of
18 March 2022;24
33. Urges relevant international financial institutions, United Nations entities,
non-governmental organizations and the private sector, as appropriate, to consider
increasing their support, including through long-term and flexible funding, for the
implementation of comprehensive and balanced development-oriented drug control
programmes and viable economic alternatives for the promotion of inclusive
economic growth and support for initiatives that contribute to poverty eradication,
inter alia, alternative development, including, as appropriate, preventive alternative
development programmes, based on identified needs and national priorities, for areas
and populations affected by or vulnerable to the illicit cultivation of drug crops, and
encourages Member States to develop measures for rural development, improving
infrastructure and social inclusion and protection and addressing the consequences of
illicit crop cultivation and the manufacture and production of narcotic drugs and
psychotropic substances on the environment, with the incorporation and participation
of local communities;
__________________
23 Resolution 68/196, annex.
24 See Official Records of the Economic and Social Council, 2022, Supplement No. 8 (E/2022/28),
chap. I, sect. B.
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
12/15
34. Calls upon Member States to ensure the participation of local
communities, including farmers, women, minorities and Indigenous Peoples, in the
design and implementation of alternative development programmes and to secure
alternative livelihoods, preferably before removing existing livelihoods earned from
the cultivation of illicit crops;
35. Also calls upon Member States to mainstream a gender perspective into
and ensure the full, equal, meaningful and effective participation of women in all
stages of the development, implementation, monitoring and evaluation of drug
policies and programmes, including drug prevention, treatment, sustained recovery,
reintegration and related support services, to develop and disseminate gender-
sensitive and age-appropriate measures that take into account the specific needs and
circumstances faced by women and girls with regard to the world drug problem and,
as States parties, implement the Convention on the Elimination of All Forms of
Discrimination against Women,25 and bearing in mind the importance of targeted
interventions that are based on the collection and analysis of data, including age- and
gender-related data, in meeting the specific needs of drug-affected populations and
communities;
36. Requests the United Nations Office on Drugs and Crime to continue to
support Member States, upon request, in mainstreaming a gender perspective into
their policies and programmes related to the world drug problem, and invites the
United Nations Entity for Gender Equality and the Empowerment of Women
(UN-Women) and other relevant United Nations entities, within their mandates, to
cooperate with the Office in this regard;
37. Encourages the consideration of the specific needs and possible multiple
vulnerabilities of women drug offenders when imprisoned, in line with the United
Nations Rules for the Treatment of Women Prisoners and Non-custodial Measures for
Women Offenders (the Bangkok Rules);
38. Calls upon Member States to adapt their drug policies and to consider,
when developing comprehensive policies to address and counter the world drug
problem, measures, programmes and actions that respond the specific needs of
members of society in situations of vulnerability;
39. Recalls the Political Declaration on HIV and AIDS: Ending Inequalities
and Getting on Track to End AIDS by 2030, adopted by the General Assembly on
8 June 2021;26
40. Invites relevant national authorities to consider, in accordance with their
domestic law and the three international drug control conventions, including in
national prevention, treatment, care, recovery, rehabilitation and community-based
social reintegration measures and programmes, in the context of comprehensive and
balanced drug demand reduction efforts, effective evidence-based measures aimed at
minimizing the adverse public health and social consequences of drug abuse,
including appropriate medication-assisted therapy programmes, injecting equipment
programmes as well as antiretroviral therapy and other relevant interventions that
prevent the transmission of HIV, viral hepatitis and other blood-borne diseases
associated with drug use, and to consider ensuring access to such interventions,
including in treatment and outreach services, prisons and other custodial settings, and
promoting in that regard the use, as appropriate, of the technical guide for countries
to set targets for universal access to HIV prevention, treatment and care for injecting
__________________
25 United Nations, Treaty Series, vol. 1249, No. 20378.
26 Resolution 75/284, annex.
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
13/15
22-29004
drug users, issued by the World Health Organization, the United Nations Office on
Drugs and Crime and the Joint United Nations Programme on HIV/AIDS;
41. Encourages Member States to identify and take advantage of opportunities
to conduct collaborative research and continuously share the latest scientific research,
taking into account the contributions of the national, regional and international
scientific community, including academia, on the most effective demand and supply
reduction strategies, and to develop improved best practices on interventions to
reduce demand for drugs, in accordance with the three international drug control
conventions and drug policy commitments;
42. Invites Member States to promote and improve the systematic collection
of information and gathering of evidence as well as the sharing, at the national and
international levels, of reliable and comparable data on drug use and epidemiology,
including scientific data on any risks or damage to health and societal consequences
that are caused by abusing drugs, including in vaporized form, and on social,
economic and other risk factors, as well as the links between drug policies and human
rights, to promote, as appropriate, through the Commission on Narcotic Drugs and
the World Health Assembly, the use of internationally recognized standards, such as
the International Standards on Drug Use Prevention, and the exchange of best
practices, and to formulate effective drug use prevention strategies and programmes
in cooperation with the United Nations Office on Drugs and Crime, the World Health
Organization and other relevant United Nations entities;
43. Also invites Member States to provide the United Nations Office on Drugs
and Crime with information on best practices and programmes recently implemented,
consistent with the three international drug control conventions, in order to assess
recent developments and current and future challenges;
44. Stresses the need for national statistical capacity-building to support
Member States in improving the quality and availability of drug statistics and to
respond effectively to data-collection requests from the United Nations Office on
Drugs and Crime, invites international and regional organizations to support Member
States in this regard, upon their request, invites Member States to regularly report
data and information relating to all aspects of the world drug problem to the Office
through the annual report questionnaires, and invites the Commission on Narcotic
Drugs, as the central policymaking body of the United Nations system on drug-related
matters, to strengthen the capacity of the Office to collect, analyse, use and
disseminate accurate, reliable, objective and comparable data and to reflect such
information in the World Drug Report;
45. Invites Member States to consider the need to review the set of national
drug policy metrics and tools for the collection and analysis of accurate, reliable,
disaggregated, comprehensive and comparable data to measure the effectiveness of
programmes to address all relevant aspects of the world drug problem, including, as
appropriate, as related to the 2030 Agenda;
46. Encourages Member States to promote data collection, research and the
sharing of information, as well as the exchange of best practices on preventing and
countering drug-related crime and on drug supply reduction measures and practices,
in order to enhance the effectiveness of criminal justice responses, within the
framework of applicable law;
47. Requests the United Nations Office on Drugs and Crime to continue
providing assistance to Member States, upon request, with regard to data collection,
research and, as appropriate, intelligence- and analysis-sharing to disclose the extent
of the links between illicit drug trafficking and firearms trafficking, and to continue
A/RES/77/238
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
22-29004
14/15
its already existing research on these links, subject to the availability of extrabudgetary
resources;
48. Calls upon Member States to intensify efforts to prevent and counter the
illicit cultivation, production and manufacture of and trafficking in narcotic drugs and
psychotropic substances, as well as drug-related crime and violence, through, inter
alia, more effective drug-related crime prevention and law enforcement measures
consistent with national legislation and international law, including applicable human
rights obligations, as well as by addressing links with other forms of organized crime,
including firearms trafficking, money-laundering, corruption and other criminal
activities, mindful of their social and economic causes and consequences;
49. Reaffirms the importance of an integrated approach in drug policies,
including by strengthening partnerships between the public health, development,
human rights, justice and law enforcement fields, as well as the private sector, in
particular chemical and pharmaceutical industries, and by facilitating inter-agency
cooperation and communication, where appropriate;
50. Recognizes that civil society, the scientific community, academia, the
private sector and affected communities can play a significant role in addressing and
countering the world drug problem by analysing drugs issues, in delivering services
and in evaluating the human rights impact of drug policies, and encourages, where
appropriate, the participation of civil society and affected communities in the design,
implementation and provision of relevant scientific evidence in support of the
evaluation of drug control policies and programmes;
51. Reaffirms the importance of the United Nations Office on Drugs and Crime
and its field offices in building capacity at the local level in the fight against
transnational organized crime and drug trafficking, encourages the Office to maintain
an effective level of support for national and regional efforts, requests all Member
States to provide the fullest possible financial and political support to the Office by
widening its donor base, as appropriate, and increasing voluntary contributions, in
particular general-purpose contributions, so as to enable it to continue, expand,
improve and strengthen, within its mandates, its operational and technical cooperation
activities, and requests the Office to continue to collaborate with relevant
intergovernmental, international and regional organizations involved in addressing
and countering the world drug problem, as appropriate, in order to share best practices
and scientific standards and to maximize the benefits from their unique comparative
advantage;
52. Takes note of the statements by the President of the International Narcotics
Control Board of 21 and 22 September 2022;
53. Requests the United Nations Office on Drugs and Crime and the
International Narcotics Control Board to continue to strengthen cooperation with the
World Health Organization and other competent United Nations entities, within their
respective mandates, as part of a comprehensive, integrated and balanced approach to
strengthening health and social welfare measures in addressing the world drug
problem, including through effective prevention, early intervention, treatment, care,
recovery, rehabilitation and social reintegration, in cooperation, as appropriate, with
civil society and the scientific community, and to keep the Commission on Narcotic
Drugs appropriately updated;
54. Requests the United Nations Office on Drugs and Crime, in close cooperation
with Member States and pertinent United Nations entities, intergovernmental and
regional organizations and the scientific community and civil society, to continue to
support Member States, upon request, in strengthening their capacity to develop their
reporting mechanisms, including through technical assistance, by identifying gaps in
Addressing and countering the world drug problem through a
comprehensive, integrated and balanced approach
A/RES/77/238
15/15
22-29004
the current drug statistics and by exploring possibilities to strengthen existing data-
collection and analysis tools at the national level; and to provide technical assistance
to Governments so as to facilitate the implementation of and enable them to fully
meet their obligations under the conventions and give adequate follow-up to
subsequent resolutions of the Commission on Narcotic Drugs, the Economic and
Social Council and the General Assembly;
55. Encourages all relevant United Nations entities, in close cooperation with
the United Nations Office on Drugs and Crime, to support Member States in
developing and implementing balanced, comprehensive, integrated, multidisciplinary,
evidence-based, development-oriented and sustainable responses to the world drug
problem, while respecting human rights, within the framework of the three
international drug control conventions;
56. Welcomes the follow-up to the implementation of all commitments to
address and counter the world drug problem made since 2009, including the
recommendations set out in the outcome document of the thirtieth special session of
the General Assembly, through the intersessional process of the Commission on
Narcotic Drugs, encourages the Commission to continue to work on and support
Member States in their implementation and sharing of scientific and evidence-based
best practices in addressing and countering the world drug problem, and invites the
Commission to continue to examine how its subsidiary bodies can better contribute
to the implementation of, inter alia, the outcome document and all relevant
commitments by ensuring that the Commission is informed of regional and domestic
concerns, developments and best practices arising from all stakeholders, including
contributions from the scientific community, academia and civil society;
57. Calls upon all Member States to actively participate in the discussions of
the Commission on Narcotic Drugs concerning the preparations for the 2024 midterm
review of the progress in implementing all international drug policy commitments,
which should include inputs by the General Assembly concerning the follow-up to
the 2019 Ministerial Declaration on Strengthening Our Actions at the National,
Regional and International Levels to Accelerate the Implementation of Our Joint
Commitments to Address and Counter the World Drug Problem;
58. Takes note of the report of the Secretary-General,27 and requests that he
submit to the General Assembly at its seventy-ninth session a report on the
implementation of the present resolution, including a focus on international
cooperation to address and counter the world drug problem.
54th plenary meeting
15 December 2022
__________________
27 A/77/137.
▶ Cite this page
UN Project. “A/RES/77/238.” UN Project, https://un-project.org/votes/resolution/A-RES-77-238/. Accessed .